Evidence map›Paper›PMID 28427322›Full record

ArticleBMC cell biology2017

Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation.

Raquel Núñez-Toldrà, Ester Martínez-Sarrà, Carlos Gil-Recio, Miguel Ángel Carrasco, Ashraf Al Madhoun, Sheyla Montori, Maher Atari

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Raquel Núñez-ToldràRegenerative Medicine Research Institute, Universitat Internacional de Catalunya, Barcelona, Spain.
Ester Martínez-SarràRegenerative Medicine Research Institute, Universitat Internacional de Catalunya, Barcelona, Spain.
Carlos Gil-RecioRegenerative Medicine Research Institute, Universitat Internacional de Catalunya, Barcelona, Spain.
Miguel Ángel CarrascoArea of Pathology, Universitat Internacional de Catalunya, Barcelona, Spain.
Ashraf Al MadhounResearch Division, Dasman Diabetes Institute, Dasman, Kuwait.
Sheyla MontoriRegenerative Medicine Research Institute, Universitat Internacional de Catalunya, Barcelona, Spain.
Maher AtariRegenerative Medicine Research Institute, Universitat Internacional de Catalunya, Barcelona, Spain. matari@uic.es.
Center of Regenerative Medicine in Barcelona · ESUniversitat Internacional de Catalunya · ESDasman Diabetes Institute · KW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBiomaterials are widely used to regenerate or substitute bone tissue. In order to evaluate their potential use for clinical applications, these need to be tested and evaluated in vitro with cell culture models. Frequently, immortalized osteoblastic cell lines are used in these studies. However, their uncontrolled proliferation rate, phenotypic changes or aberrations in mitotic processes limits their use in long-term investigations. Recently, we described a new pluripotent-like subpopulation of dental pulp stem cells derived from the third molars (DPPSC) that shows genetic stability and shares some pluripotent characteristics with embryonic stem cells. In this study we aim to describe the use of DPPSC to test biomaterials, since we believe that the biomaterial cues will be more critical in order to enhance the differentiation of pluripotent stem cells.

methodsThe capacity of DPPSC to differentiate into osteogenic lineage was compared with human sarcoma osteogenic cell line (SAOS-2). Collagen and titanium were used to assess the cell behavior in commonly used biomaterials. The analyses were performed by flow cytometry, alkaline phosphatase and mineralization stains, RT-PCR, immunohistochemistry, scanning electron microscopy, Western blot and enzymatic activity. Moreover, the genetic stability was evaluated and compared before and after differentiation by short-comparative genomic hybridization (sCGH).

resultsDPPSC showed excellent differentiation into osteogenic lineages expressing bone-related markers similar to SAOS-2. When cells were cultured on biomaterials, DPPSC showed higher initial adhesion levels. Nevertheless, their osteogenic differentiation showed similar trend among both cell types. Interestingly, only DPPSC maintained a normal chromosomal dosage before and after differentiation on 2D monolayer and on biomaterials.

conclusionsTaken together, these results promote the use of DPPSC as a new pluripotent-like cell model to evaluate the biocompatibility and the differentiation capacity of biomaterials used in bone regeneration.

Indexed as

AdolescentBiocompatible MaterialsCell Culture TechniquesCell DifferentiationCell Line, TumorCells, CulturedChromosomal InstabilityComparative Genomic HybridizationDental PulpFemaleHumansMaleMaterials TestingMolar, ThirdOsteogenesisPluripotent Stem CellsBiocompatible MaterialsBiomaterialsDental pulpGenetic stabilityOsteogenic differentiationPluripotencyStem cells

Identifiers

PMID28427322
PMCPMC5399345
OpenAlexW2607410601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.